An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology. 1999 Dec; 117(6):1278-87.